These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1628973)

  • 21. [Sneddon syndrome and antiphospholipid antibodies].
    Montalbán J
    Med Clin (Barc); 1988 Sep; 91(7):277. PubMed ID: 3193838
    [No Abstract]   [Full Text] [Related]  

  • 22. Sneddon's syndrome: an antiphospholipid antibody syndrome?
    Levine SR; Langer SL; Albers JW; Welch KM
    Neurology; 1988 May; 38(5):798-800. PubMed ID: 3129674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
    Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
    Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
    Mojzes J; Battyáni Z; Grexa E
    Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sneddon syndrome: diagnostic value of antiphospholipid antibodies].
    Martínez Hernández PL; López Guzmán A; Espinosa Arranz E; Monereo Alonso A; Arnalich Fernández F
    Rev Clin Esp; 1991 Oct; 189(6):272-4. PubMed ID: 1763211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimmune thrombocytopenia in two patients with Sneddon's Syndrome.
    Meyer O; Worm M; Kiesewetter H; Salama A
    Thromb Haemost; 2007 Dec; 98(6):1368-70. PubMed ID: 18064338
    [No Abstract]   [Full Text] [Related]  

  • 27. Sneddon's syndrome: another migraine-stroke association?
    Tietjen GE; Al-Qasmi MM; Gunda P; Herial NA
    Cephalalgia; 2006 Mar; 26(3):225-32. PubMed ID: 16472327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sneddon's syndrome and the primary antiphospholipid syndrome].
    Kalashnikova LA; Nasonov EL; Stoianovich LZ; Kovalev VIu; Kosheleva NM; Reshetniak TM
    Ter Arkh; 1993; 65(3):64-70. PubMed ID: 8059389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sneddon syndrome and antiphospholipid antibodies].
    Khamashta MA; Asherson RA; Gil A; Hughes GR
    Med Clin (Barc); 1988 Oct; 91(13):514-5. PubMed ID: 3226203
    [No Abstract]   [Full Text] [Related]  

  • 30. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies.
    Jonas J; Kölble K; Völcker HE; Kalden JR
    Am J Ophthalmol; 1986 Jul; 102(1):37-40. PubMed ID: 3524244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sneddon's syndrome and antiphospholipid antibodies: clarification of a controversy by skin biopsy?
    Stockhammer GJ; Felber SR; Aichner FT; Zelger B; Sepp N; Fritsch P
    Stroke; 1992 Aug; 23(8):1182-3. PubMed ID: 1636199
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticardiolipin antibodies in Sneddon's syndrome.
    Kalashnikova LA; Nasonov EL; Kushekbaeva AE; Gracheva LA
    Neurology; 1990 Mar; 40(3 Pt 1):464-7. PubMed ID: 2314589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rarely seen syndrome in rehabilitation of hemiplegia: antiphospholipid antibody-negative Sneddon's syndrome.
    Akbal A; Kurtaran A; Selçuk B; Ersöz M; Akyüz M
    Rheumatol Int; 2010 Sep; 30(11):1489-91. PubMed ID: 19697034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sneddon's syndrome [].
    Weber M
    Ann Dermatol Venereol; 1990; 117(12):923. PubMed ID: 2082785
    [No Abstract]   [Full Text] [Related]  

  • 35. Sneddon's syndrome.
    Asherson RA; Khamashta MA; Hughes GR
    Neurology; 1989 Aug; 39(8):1138-9. PubMed ID: 2761716
    [No Abstract]   [Full Text] [Related]  

  • 36. Cutaneous manifestations of antiphospholipid syndrome.
    Gomez-Flores M; Herrera-Argaez G; Vazquez-Martinez O; Herz-Ruelas M; Ocampo-Candiani J; Villarreal-Martinez A; Galarza-Delgado DA; Hernandez-Galarza I; Chavez-Alvarez S
    Lupus; 2021 Apr; 30(4):541-548. PubMed ID: 33583236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sneddon's syndrome: clinical and immunohistochemical findings.
    Fetoni V; Berti E; Cecca E; Carella F; Sinico RA; Girotti F
    Clin Neurol Neurosurg; 1994 Nov; 96(4):310-3. PubMed ID: 7889693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sneddon's syndrome: case report and review of its relationship with antiphospholipid syndrome.
    Dutra LA; Braga-Neto P; Pedroso JL; Barsottini OG
    Einstein (Sao Paulo); 2012; 10(2):230-2. PubMed ID: 23052460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to prothrombin in patients with Sneddon's syndrome.
    Kalashnikova LA; Korczyn AD; Shavit S; Rebrova O; Reshetnyak T; Chapman J
    Neurology; 1999 Jul; 53(1):223-5. PubMed ID: 10408567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.